Pasithea Therapeutics (KTTA) Change in Cash (2021 - 2026)
Pasithea Therapeutics recorded quarterly Change in Cash of -$4.8 million in Q1 2026, down 109.32% quarter-over-quarter from $51.0 million in Q4 2025, and down 200.88% year-over-year from $4.7 million in Q1 2025.
Pasithea Therapeutics' Change in Cash history runs 6 years deep, the most recent figure standing at -$4.8 million for Q1 2026.
- In Q1 2026, Change in Cash fell 200.88% year-over-year to -$4.8 million; the TTM figure through Mar 2026 stood at $45.2 million (up 777.26% YoY), while the FY2025 annual figure was $48.3 million, up 613.77% from the prior year.
- Change in Cash came in at -$4.8 million for Q1 2026 at Pasithea Therapeutics, down from $51.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $51.0 million in Q4 2025 to a low of -$9.3 million in Q4 2022.
- A 5-year average of -$141205.6 and a median of -$3.2 million in 2023 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash sank 423.6% in 2022 and surged 2192.99% in 2025, its largest moves.
- Pasithea Therapeutics' Change in Cash stood at -$9.3 million in 2022, then jumped by 64.98% to -$3.3 million in 2023, then increased by 25.05% to -$2.4 million in 2024, then soared by 2192.99% to $51.0 million in 2025, then tumbled by 109.32% to -$4.8 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered -$4.8 million, $51.0 million, and -$3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 623.00 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 417.10 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -153.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.61 Mn |
| 10 | Pasithea Therapeutics | 17.41 Mn | 17.41 Mn | - | -4.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.76 Mn |
| Dec 31, 2025 | 51.04 Mn |
| Sep 30, 2025 | -2.99 Mn |
| Jun 30, 2025 | 1.88 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -2.44 Mn |
| Sep 30, 2024 | 1.39 Mn |
| Jun 30, 2024 | -4.04 Mn |
| Mar 31, 2024 | -4.32 Mn |
| Dec 31, 2023 | -3.25 Mn |
| Sep 30, 2023 | -7.06 Mn |
| Jun 30, 2023 | -3.27 Mn |
| Mar 31, 2023 | -3.17 Mn |
| Dec 31, 2022 | -9.29 Mn |
| Sep 30, 2022 | -5.52 Mn |
| Jun 30, 2022 | -2.33 Mn |
| Mar 31, 2022 | -2.68 Mn |
| Dec 31, 2021 | 32.40 Mn |
| Sep 30, 2021 | 20.00 Mn |
| Jun 30, 2021 | -501,750.00 |
| Mar 31, 2021 | 827,081.00 |